⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL270229 | 0.69 | — | — | |
| SCHEMBL11600202 | 0.67 | — | — | |
| SCHEMBL5079747 | 0.67 | — | — | |
| SCHEMBL483574 | 0.67 | — | — | |
| SCHEMBL20221346 | 0.67 | — | — | |
| SCHEMBL195747 | 0.65 | — | — | |
| SCHEMBL13849138 | 0.65 | — | — | |
| SCHEMBL8322720 | 0.63 | — | — | |
| SCHEMBL9578953 | 0.63 | TDP1 (0.30) | — | |
| SCHEMBL902771 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250280857-A1 | DEGRADATION-RESISTANT ALDEHYDE-CONTAINING COMPOSITIONS | ZOOMESSENCE INC (US) | 2025-09-11 | — | — | US | claimed |
| WO-2023215706-A1 | DEGRADATION-RESISTANT ALDEHYDE-CONTAINING COMPOSITIONS | ZoomEssence, Inc. (US) | 2023-11-09 | — | — | WO | claimed |
| US-20260118304-A1 | ODOR SIGNATURE IDENTIFICATION SYSTEM | CHANDRA SHUBHAM (US) | 2026-04-30 | — | — | US | disclosed |
| US-20250280857-A1 | DEGRADATION-RESISTANT ALDEHYDE-CONTAINING COMPOSITIONS | ZOOMESSENCE INC (US) | 2025-09-11 | — | — | US | disclosed |
| US-RE49918-E1 | Cytotoxic benzodiazepine derivatives | IMMUNOGEN, INC. (US) | 2024-04-16 | — | — | US | disclosed |
| WO-2023215706-A1 | DEGRADATION-RESISTANT ALDEHYDE-CONTAINING COMPOSITIONS | ZoomEssence, Inc. (US) | 2023-11-09 | — | — | WO | disclosed |
| US-11505617-B2 | Benzodiazepine derivatives | IMMUNOGEN, INC. (US) | 2022-11-22 | — | — | US | disclosed |
| CN-108727407-B | Novel benzodiazepine derivatives | 伊缪诺金公司 | 2022-01-28 | — | — | CN | disclosed |
| CN-113661172-A | Cytotoxic bis-benzodiazepine derivatives and conjugates thereof with cell-binding agents for use in inhibiting abnormal cell growth or treating proliferative diseases | 伊缪诺金公司 | 2021-11-16 | — | — | CN | disclosed |
| CN-107335061-B | Cytotoxic benzodiazepine derivatives | 伊缪诺金公司 | 2021-09-07 | — | — | CN | disclosed |
| US-20210238301-A1 | NOVEL BENZODIAZEPINE DERIVATIVES | IMMUNOGEN, INC. | 2021-08-05 | — | — | US | disclosed |
| WO-2011023883-A1 | CONJUGATES OF PYRROLO[1,4]BENZODIAZEPINE DIMERS AS ANTICANCER AGENTS | SANOFI-AVENTIS (FR) | 2011-03-03 | — | — | WO | disclosed |
| WO-2011001052-A1 | NOVEL CONJUGATES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF | SANOFI-AVENTIS (FR) | 2011-01-06 | — | — | WO | disclosed |
| US-20100203007-A1 | NOVEL BENZODIAZEPINE DERIVATIVES | IMMUNOGEN INC. (US) | 2010-08-12 | — | — | US | disclosed |
| WO-2010091150-A1 | NOVEL BENZODIAZEPINE DERIVATIVES | IMMUNOGEN, INC. (US) | 2010-08-12 | — | — | WO | disclosed |
| US-20090311403-A1 | Method of Using Organic Compounds | GIVAUDAN SA (CH) | 2009-12-17 | — | — | US | disclosed |
| EP-2046147-A1 | METHOD OF USING ORGANIC COMPOUNDS | Givaudan SA (CH) | 2009-04-15 | — | — | EP | disclosed |
| EP-1981889-A1 | CYTOTOXIC AGENTS COMPRISING NEW TOMAYMYCIN DERIVATIVES AND THEIR THERAPEUTIC USE | Sanofi-Aventis (FR) | 2008-10-22 | — | — | EP | disclosed |
| WO-2008011742-A1 | METHOD OF USING ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2008-01-31 | — | — | WO | disclosed |
| WO-2007085930-A1 | CYTOTOXIC AGENTS COMPRISING NEW TOMAYMYCIN DERIVATIVES AND THEIR THERAPEUTIC USE | SANOFI-AVENTIS (FR) | 2007-08-02 | — | — | WO | disclosed |